Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
13 angezeigte Treffer · Seite 1, keine Gesamtzahl für „Entyvio · 4.8 · Infections“
Suchtreffer
Begriffe & Kennungen
Entyvio · 4.8 · 27 In clinical studies with intravenous and subcutaneous vedolizumab, the rate of infections in vedolizumab-tr
Eintrag öffnenEntyvio · 4.8 · In GEMINI 1 and 2 controlled studies with intravenous vedolizumab, the rate of infections was 0.85 per patient
Eintrag öffnenEntyvio · 4.8 · In GEMINI 1 and 2 controlled studies with intravenous vedolizumab, the rate of serious infections was 0.07 per
Eintrag öffnenEntyvio · 4.8 · In GEMINI 1 and 2 controlled studies with intravenous vedolizumab, the rate of serious infections was 0.07 per
Eintrag öffnenEntyvio · 4.8 · In clinical studies with subcutaneous vedolizumab, the rate of infections was 0.26 per patient year in vedoliz
Eintrag öffnenEntyvio · 4.8 · In clinical studies with subcutaneous vedolizumab, the rate of serious infections was 0.02 per patient year in
Eintrag öffnenEntyvio · 4.8 · In controlled and open-label studies in adults with intravenous vedolizumab, serious infections have been repo
Eintrag öffnenEntyvio · 4.8 · Infections
Eintrag öffnenEntyvio · 4.8 · Infections
Eintrag öffnenEntyvio · 4.8 · Table 1. Adverse reactions System organ class Frequency Adverse reactions Infections and infestations Very com
Eintrag öffnenEntyvio · 4.8 · Table 1. Adverse reactions System organ class Frequency Adverse reactions Infections and infestations Very com
Eintrag öffnenEntyvio · 4.8 · The most commonly reported adverse reactions are infections (such as nasopharyngitis, upper respiratory tract
Eintrag öffnenEntyvio · 4.8 · The most commonly reported adverse reactions are infections (such as nasopharyngitis, upper respiratory tract
Eintrag öffnen